Fetal Hemoglobin Regulation in Beta-Thalassemia
Henry Y Lu1, Stuart H Orkin2, Vijay G Sankaran3
1Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Karp Family Research Laboratories, Boston Children's Hospital, 1 Blackfan Street, Boston, MA 02115, USA. Electronic address: https://twitter.com/realhenrylu.
Beta-thalassemia, a genetic blood disorder, causes anemia due to reduced beta-globin production. Boosting fetal hemoglobin (HbF) offers a promising therapeutic strategy by compensating for this deficiency.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Beta-thalassemia results from mutations impairing beta-globin synthesis, leading to ineffective red blood cell production and anemia.
- Elevated fetal hemoglobin (HbF) levels can mitigate disease severity by counteracting globin chain imbalance.
Purpose of the Study:
- To explore the genetic regulators of fetal hemoglobin (HbF) switching.
- To identify novel therapeutic targets for increasing HbF levels in beta-thalassemia patients.
Main Methods:
- Leveraging human genetics, population studies, and functional genomic screens.
- Utilizing genome editing and other advanced molecular tools to discover HbF regulators.
Main Results:
- Key regulators of HbF switching, such as BCL11A and ZBTB7A, have been identified.
- Recent screens have uncovered numerous novel HbF regulators.
Conclusions:
- Understanding HbF regulation is crucial for developing effective beta-thalassemia treatments.
- Newly discovered HbF regulators hold potential for improving therapeutic HbF induction strategies.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
01:20Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
02:16Transcription Factors
01:30General Transcription Factors
01:28Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
01:24Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...